Ubs Group Ag Enochian Biosciences Inc Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Ubs Group Ag holds 19,789 shares of ENOB stock, worth $91,029. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,789

Previous 1,849 970.25%

Holding current value

$91,029

Previous $8,000 1037.5%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	N/A	17,940 Added 970.25%	19,789 $91,000
Q1 2024 May 13, 2024	SELL	N/A	-6,298 Reduced 77.3%	1,849 $8,000
Q4 2023 Feb 09, 2024	BUY	$4.3 - $4.7 $9,137 - $9,987	2,125 Added 35.29%	8,147 $37,000
Q3 2023 Nov 09, 2023	BUY	$0.0 - $4.46 $0 - $26,858	6,022 New	6,022 $26,000
Q1 2023 May 12, 2023	BUY	$0.91 - $1.31 $1,149 - $1,654	1,263 Added 20.68%	7,369 $6,000
Q4 2022 Feb 08, 2023	BUY	$1.03 - $2.13 $6,289 - $13,005	6,106 New	6,106 $6,000
Q2 2022 Aug 10, 2022	SELL	$1.93 - $8.73 $3,937 - $17,809	-2,040 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.42 - $9.0 $8,238 - $16,776	1,864 Added 1059.09%	2,040 $17,000
Q4 2021 Feb 14, 2022	BUY	$6.71 - $12.55 $1,080 - $2,020	161 Added 1073.33%	176 $1,000
Q3 2021 Nov 15, 2021	SELL	$4.56 - $7.88 $1,117 - $1,930	-245 Reduced 94.23%	15 $0
Q2 2021 Aug 13, 2021	SELL	$2.94 - $6.79 $9,675 - $22,345	-3,291 Reduced 92.68%	260 $1,000
Q1 2021 May 12, 2021	BUY	$3.02 - $4.51 $483 - $721	160 Added 4.72%	3,551 $13,000
Q4 2020 Feb 11, 2021	BUY	$2.82 - $3.55 $9,373 - $11,800	3,324 Added 4961.19%	3,391 $10,000
Q3 2020 Nov 12, 2020	SELL	$3.42 - $4.55 $19,220 - $25,571	-5,620 Reduced 98.82%	67 $0
Q2 2020 Jul 31, 2020	SELL	$2.78 - $6.06 $9,307 - $20,288	-3,348 Reduced 37.06%	5,687 $24,000
Q1 2020 May 01, 2020	SELL	$2.08 - $5.41 $22,326 - $58,070	-10,734 Reduced 54.3%	9,035 $27,000
Q4 2019 Feb 14, 2020	BUY	$3.48 - $6.75 $58,122 - $112,738	16,702 Added 544.57%	19,769 $99,000
Q3 2019 Nov 14, 2019	BUY	$3.95 - $5.72 $9,254 - $13,401	2,343 Added 323.62%	3,067 $17,000
Q2 2019 Aug 14, 2019	BUY	$4.5 - $6.99 $3,258 - $5,060	724 New	724 $3,000
Q1 2019 May 14, 2019	SELL	$5.82 - $9.25 $11,314 - $17,982	-1,944 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.17 - $8.48 $10,050 - $16,485	1,944 New	1,944 $14,000

Others Institutions Holding ENOB

# of Institutions

Shares Held

14M

Call Options Held

33.7K

Put Options Held

View Full List

About Enochian Biosciences Inc

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

More about ENOB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account